Similarly, increased expression/activation of other tumor microenvironment modulators, such as matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer, was found to be associated, at least partially, with the expression of HER)-2/neu in ER-positive disease and predicted malignancy and poor survival [46]. The gene discussed is ESR1; the disease is breast carcinoma.